FDA Approves Zidesamtinib for ROS1-Positive Lung Cancer After Progression
The agency cleared Jideytro on July 22, 2026 for patients whose ROS1-positive non-small cell lung cancer advanced on a prior ROS1 inhibitor.
Health News
Drug approvals, product recalls, safety advisories and revised clinical guidance, written so a reader knows immediately whether it applies to them.
FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
Merck's once-daily Lipfendra (enlicitide) cut LDL cholesterol by nearly 60 percent in trials and offers an alternative to injections.
FDA Approves Lumvoa for Thyroid Eye Disease, Including Chronic Cases
The second IGF-1R antibody cleared for the condition extends targeted treatment to patients in both active and chronic stages, its developer says.
FDA Approves First Oral Antiviral to Prevent COVID-19 After Exposure
Xocova (ensitrelvir) cut the risk of symptomatic infection by about 67 percent in the SCORPIO-PEP trial and is cleared for people 12 and older.
FDA Approves Foundayo, an Oral GLP-1 Pill for Weight Management
Eli Lilly's orforglipron delivered an average 12.4 percent weight loss at the highest dose in trials and can be taken without food or water restrictions.
FDA Approves First-Ever Treatment for Menkes Disease in Children
The agency cleared copper histidinate injection, ending a decades-long stretch in which care for the rare copper-transport disorder was supportive only.